Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, August 2001, p. 2372-2374, Vol. 45, No. 8
Department of Clinical Microbiology, Hospital
Clínico San Carlos, 28040 Madrid, Spain
Received 17 January 2001/Returned for modification 29 March
2001/Accepted 16 May 2001
The activity of MK-0826, a new carbapenem, against 309 Bacteroides fragilis group strains was investigated and
compared with that of 11 other
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.8.2372-2374.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
In Vitro Activities of MK-0826 and 16 Other
Antimicrobials against Bacteroides fragilis Group
Strains
-lactam and 5 non-
-lactam agents.
MK-0826 showed excellent activity (MICs ranged from
0.06 to 4 µg/ml). The new carbapenem may be useful in the treatment of mixed
anaerobic infections involving B. fragilis group strains.
*
Corresponding author. Mailing address: Department of
Clinical Microbiology, Hospital Clínico San Carlos, Plaza
Cristo Rey s/n, 28040 Madrid, Spain. Phone: 34 913303484. Fax: 34 913303478. E-mail: cbetriu{at}efd.net.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»